Yiska Weisblum

Rockefeller University — United States

Medicine · Health Sciences

35h-index12.0kcitations55works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(37), COVID-19 Clinical Research Studies(14), Cytomegalovirus and herpesvirus research(10), SARS-CoV-2 detection and testing(10), Viral gastroenteritis research and epidemiology(9)

Publications55 total

Gut microbiota-derived metabolites confer protection against SARS-CoV-2 infection
Gut Microbes·2022· 51 citedOpen Access
Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
Open Forum Infectious Diseases·2022· 6 citedOpen Access
VPS29 Exerts Opposing Effects on Endocytic Viral Entry
mBio·2022· 10 citedOpen Access
Author response: Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
2022· 1 citedOpen Access
SARS-CoV-2 neutralization after mRNA vaccination and variant breakthrough infection
2022· 2 citedOpen Access
Plasma neutralization properties of the SARS-CoV-2 Omicron variant
2021· 87 citedOpen Access
Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
eLife·2021· 70 citedOpen Access
Author response: Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
2021Open Access
Replication and single-cycle delivery of SARS-CoV-2 replicons
Science·2021· 81 citedOpen Access
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Nature·2021· 237 citedOpen Access
Mass Spectrometry Datasets for "Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape"
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
Mass Spectrometry Datasets for "Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape"
Zenodo (CERN European Organization for Nuclear Research)·2021Open Access
VPS29 exerts opposing effects on endocytic viral entry
2021· 2 citedOpen Access
High genetic barrier to escape from human polyclonal SARS-CoV-2 neutralizing antibodies
2021· 23 citedOpen Access
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Immunity·2021· 307 citedOpen Access
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Nature Communications·2021· 463 citedOpen Access
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Cell·2021· 99 citedOpen Access
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2
2021· 10 citedOpen Access
Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry
2021· 18 citedOpen Access
Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
2021· 47 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Paul D. Bieniasz(34), Théodora Hatziioannou(30), Fabian Schmidt(29), Frauke Muecksch(25), Michel C. Nussenzweig(23), Christian Gaebler(22), Marina Caskey(22), Zijun Wang(18), Alice Cho(18), Dana G. Wolf(15), Davide F. Robbiani(14), Christopher O. Barnes(13), Anna Gazumyan(13), Melissa Cipolla(13), Pamela J. Björkman(13), Daniel Poston(13), Julio C. C. Lorenzi(12), Shlomo Finkin(12), Katrina G. Millard(12), Magdalena Rutkowska(10)